Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson's disease: a prospective cohort study.

Junyu LinRuwei OuChunyu LiYanbing HouLingyu ZhangQianqian WeiDejiang PangKuncheng LiuQirui JiangTianmi YangYi XiaoBi ZhaoXueping ChenWei SongJing YangYing WuHui Fang Shang

Published in: BMC medicine (2023)

Plasma GFAP might be a potential biomarker for monitoring and predicting disease progression in PD.

Keyphrases

ionic liquid
neuropathic pain
protein protein
binding protein